NSC |
Compound |
Enrichment |
Correlation |
NSC 719177 |
Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]-, 1-adamantaneethyl ester |
0.0112425217758228 |
-0.32109994 |
NSC 726768 |
5,6-Dihydro-6-[(4-tert-butyloxycarbonylamino)-1-butyl]-5,11- dioxo-11H-indeno[1,2-c]isoquinoline |
0.0112425217758228 |
-0.13638084 |
NSC 734977 |
Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate |
0.0112425217758228 |
0.29336562 |
NSC 742327 |
(3-Difluoromethyl-6,7-dimethyl-1,4-dioxy-quinoxalin-2-yl)-phenyl-methanone |
0.0112425217758228 |
-0.25384629 |
NSC 127128 |
Null |
0.0112425217758229 |
0.50021397 |
NSC 237020 |
TA 1067 |
0.0112425217758229 |
-0.19432814 |
NSC 339638 |
2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt |
0.0112425217758229 |
-0.29675123 |
NSC 348121 |
4,6-Methano-5H-benz[h]oxazolo[3,2-a]pyrazino-[3,2,1-de][1,5]naphthyridine-7-carbonitrile, 1,2,3a,4,4a,6,7,9,10,13,13b,13c-dodecahydro-9-(hydroxymethyl)-11-methoxy-5,12-dimethyl-10,13-dioxo- |
0.0112425217758229 |
-0.16313399 |
NSC 633713 |
N.ALPHA.-(4-AMINO-4-DEOXYLPTEROYL)-N.DELTA.-HEMIPHTHALOYL-L-ORNITHINE |
0.0112425217758229 |
-0.26563426 |
NSC 643813 |
3'-O-(Carboxymethyl)-(Z)-Combretastatin 4-A, Na salt, hydrate [1:1:2] |
0.0112425217758229 |
-0.19666947 |